Skip to content

An explotive study on the application of individual titanium mesh for bone augmentation before implant restoration

An explotive study on the application of individual titanium mesh for bone augmentation before implant restoration

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035403
Enrollment
Unknown
Registered
2020-08-10
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alveolar ridge defect

Interventions

trial group:alveolar bone augmentation with individual titanium mesh

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Male or female patients aged 18 to 65 years; 2) Single or mutiple teeth lost needed implant restoration, the loss of anterior teeth at least 1 month, and the loss of posterior teeth at least 3 months; 3) Patients had bone defects both vertically and horizontally in a prosthetic-guided implant placement; 4) Adequate residual alveolar bone height to palce a implant with length >= 8mm; 5) Participants signed informed consent before the implementation of any study.

Exclusion criteria

Exclusion criteria: 1) Localized inflammation of adjacent teeth (uncontrolled periodontitis included); 2) Untreated acute and chronic periapical periodontitis of adjacent teeth; 3) Oral mucosal lesions (such as lichen planus); 4) Occupying lesions of adjacent teeth (including cyst, tumor, etc.); 5) Systemic disease that affecting bone healingwound healing and dental implant placement (including uncontrolled diabetes, fasting glucose >= 8.8mmol/l); 6) Uncontrolled and severe hypertension; 7) Contraindications of irregular implant placement and oral surgery(bone grafting included); 8) Heart disease (grade II and above); 9) Liver and kidney dysfunction or abnormality; 10) History of whole dose radiotherapy and local radiotherapy of the head and neck; 11) Long-term high-dose steroids therapy; 12) Treatment with drugs that may affect or promote bone metabolism in the past 3 months; 13) Alcohol or drug abuse; 14) Immunologic inadequacy ; 15) Smoking habit of more than 10 cigarettes per day; 16) Neurological or psychiatric handicap that could interfere with good oral hygiene.

Design outcomes

Primary

MeasureTime frame
vertical bone augmentation;horizontal bone augmentation;

Secondary

MeasureTime frame
the condition of soft tissue healin;bone quality;Visual Analogue Scale/Score, VAS;

Countries

China

Contacts

Public ContactWang Yueping

Ninth People's Hospital, Shanghai Jiaotong University, School of Medicine

2832533172@qq.com+86 18019791289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026